SECURITIES AND EXCHANGE COMMISSION
Washington D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of report (Date of earliest event reported): April 14, 2000
DR. ABRAVANEL'S FORMULAS, INC.
------------------------------------------------------
(Exact name of registrant as specified in its charter)
Nevada 000-25157 95-4685068
- ----------- ------------ ------------------
(State of (Commission (I.R.S. Employer
Incorporation) File Number) Identification No.)
124 South Hudson Avenue
Los Angeles CA 90004
----------------------------------------
(Address of principal executive offices)
(213) 933-0163
----------------------------------------------------
(Registrant's telephone number, including area code)
Not applicable
-----------------------------------------------------------
(Former name or former address, if changed since last report)
<PAGE>
Item 4. Changes in Registrant's Certifying Accountant.
Effective April 14, 2000, Balmer and Nelson resigned as the independent
accountant for Dr. Abravanel's Formulas, Inc. (the "Company").
Balmer & Nelson previously audited the balance sheet of Dr. Abravanel's
Formulas Inc. as of February 28, 1999, and the related statements of
operations, stockholders' equity, and cash flows for the period from April 28,
1998 (inception) through February 28, 1999. Balmer and Nelson has not issued
an adverse opinion or a disclaimer of opinion, nor has any report during the
past year been qualified or modified as to uncertainty, audit scope, or
accounting principles.
During the Company's most recent fiscal year, and any subsequent interim
period preceding the resignation of Balmer and Nelson, there were no
disagreements with Balmer and Nelson on any matter of accounting principles or
practices, financial statement disclosure, or auditing scope or procedure.
During the Company's most recent fiscal year and any subsequent interim period
preceding this change in certified accountants,
(A) Balmer and Nelson did not advise the Company that the
internal controls necessary for us to develop reliable financial statements do
not exist;
(B) Balmer and Nelson did not advise the Company that
information had come to the accountant's attention that led it to no longer be
able to rely on management's representations, or that made it unwilling to be
associated with the financial statements prepared by management;
(C) Balmer and Nelson did not advise the Company of the need to
expand significantly the scope of its audit, or that information had come to
the accountant's attention during said time period that if further
investigated, may: (i) materially impact the fairness or reliability of
either: a previously issued audit report or the underlying financial
statements, or the financial statements issued or to be issued covering the
fiscal period(s) subsequent to the date of the most recent financial
statements covered by an audit report (including information that may prevent
it from rendering an unqualified audit report on those financial statements),
or (ii) cause it to be unwilling to rely on management's representations or be
associated with the Company's financial statements; or
(D) Balmer and Nelson did not advise the Company that
information had come to the accountant's attention that it had concluded
materially impacted the fairness or reliability of either (i) a previously
issued audit report or the underlying financial statements, or (ii) the
financial statements issued or to be issued covering the fiscal period(s)
subsequent to the date of the most recent financial statements covered by an
audit report (including information that, unless resolved to the accountant's
satisfaction, would prevent it from rendering an unqualified audit report on
those financial statements).
On April 14, 2000, the Company engaged Randy R. Simpson, C.P.A., P.C. as the new
independent accountant engaged as the principal accountant to audit the
Company's financial statements. During Dr. Abravanel's two most recent fiscal
years, and any subsequent interim period prior to engaging Randy R. Simpson,
neither the Company nor someone on its behalf consulted Randy R. Simpson
regarding either: (1) the application of accounting principles to a specified
transaction, either completed or proposed; or (2) the type of audit opinion
that might be rendered on Dr. Abravanel's financial statements; or (3) any
matter which was either the subject of a disagreement (there were no
<PAGE>
disagreements as stated above) or a reportable event (as described in Item
304(a)(1)(V) of Regulation S-K).
The decision to engage the Company's new accountant, Randy R. Simpson, was
recommended and approved by the Company's board of directors.
Item 7. Financial Statements and Exhibits.
(C) Exhibits
Exhibit
No. Exhibit Description
- ---- --------------------
16.1 Letter regarding resignation of certifying accountant.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
DR ABRAVANEL'S FORMULAS, INC.
(Registrant)
Date: April 19, 2000 By: /s/ Mark Delott
--------------------------
Mark Delott
Vice -President
Secretary/Treasurer
Director
BALMER AND NELSON
CERTIFIED PUBLIC ACCOUNTANT
P.O. BOX 360
FAIRFIELD, IOWA 52556
515-472-4773
April 19, 2000
Securities and Exchange Commission
450 Fifth Street, N.W.
Washington, D.C. 20549
Dear Sirs:
Re: Dr Abravanel's Formulas, Inc.
We have read "Item 4.Changes in Registrant's Certifying Accountant" of Dr.
Abravanel's Formulas, Inc.'s Form 8-K dated April 14, 2000 and are in
agreement with the statements contained therein so far as those statements
pertain to the accounting firm of Balmer and Nelson.
Yours very truly,
/s/ Balmer and Nelson
Balmer and Nelson
